Net loss of Bafna Pharmaceuticals reported to Rs 0.72 crore in the quarter ended June 2024 as against net profit of Rs 6.35 crore during the previous quarter ended June 2023. Sales declined 20.64% to Rs 33.29 crore in the quarter ended June 2024 as against Rs 41.95 crore during the previous quarter ended June 2023.
| Particulars | Quarter Ended |
| Jun. 2024 | Jun. 2023 | % Var. |
| Sales | 33.29 | 41.95 | -21 |
| OPM % | 3.63 | 14.99 | - |
| PBDT | 1.07 | 7.56 | -86 |
| PBT | -0.37 | 6.35 | PL |
| NP | -0.72 | 6.35 | PL |